These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 15663764

  • 1. Model for gene-environment interaction: the case for dialysis.
    Liangos O, Balakrishnan VS, Jaber BL, DialGene Consortium.
    Semin Dial; 2005; 18(1):41-6. PubMed ID: 15663764
    [Abstract] [Full Text] [Related]

  • 2. Gene polymorphism association studies in dialysis: bone and mineral metabolism.
    Erturk S, DialGene Consortium.
    Semin Dial; 2006; 19(3):232-7. PubMed ID: 16689975
    [Abstract] [Full Text] [Related]

  • 3. Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients.
    Al-Muhanna F, Al-Mueilo S, Al-Ali A, Larbi E, Rubaish A, Abdulmohsen MF, Al-Zahrani A, Al-Ateeq S.
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):937-41. PubMed ID: 18974580
    [Abstract] [Full Text] [Related]

  • 4. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
    Buraczynska M, Ksiazek P, Drop A, Zaluska W, Spasiewicz D, Ksiazek A.
    Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
    [Abstract] [Full Text] [Related]

  • 5. Gene polymorphism association studies in dialysis: cardiovascular disease.
    Rao M, Jaber BL, Balakrishnan VS, DialGene Consortium.
    Semin Dial; 2005 Apr; 18(3):217-25. PubMed ID: 15934969
    [Abstract] [Full Text] [Related]

  • 6. Searching for a genetic risk profile in end-stage renal disease.
    Buraczyńska M, Ksiazek A.
    Med Sci Monit; 2001 Apr; 7(6):1376-80. PubMed ID: 11687758
    [Abstract] [Full Text] [Related]

  • 7. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
    Akman B, Tarhan C, Arat Z, Sezer S, Ozdemir FN.
    Ren Fail; 2009 Apr; 31(3):196-200. PubMed ID: 19288324
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gene polymorphism association studies in dialysis: anemia and host immunity.
    Girndt M, Heine GH, Köhler H, DialGene Consortium.
    Semin Dial; 2006 Apr; 19(3):227-31. PubMed ID: 16689974
    [Abstract] [Full Text] [Related]

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 16. [Renal sclerosis and its treatment. Conclusions].
    Ardaillou R.
    J Soc Biol; 2002 Nov; 196(4):293-4. PubMed ID: 12645298
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preventing end stage renal disease in diabetic patients--genetic aspect (part I).
    Jacobsen PK.
    J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):1-14. PubMed ID: 16088846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.